3.6. Identification of Compounds Isolated from H. diffusa
3.6.1. E-6-O-p-Coumaroyl Scandoside Methyl Ester (1)
C26H30O13; ESI/LTQ-Orbitrap-HRMS m/z: 549.1610 [M−H]−; 1H-NMR (CD3OD): 7.60 (1H, d, J = 7.8 Hz, H-7′), 7.56 (1H, s, H-3), 7.42 (2H, d, J = 9.0 Hz, H-2″,6″), 6.76 (2H, d, J = 8.4 Hz, H-3″,5″), 6.29 (1H, d, J = 15.6 Hz, H-8′), 5.80 (1H, m, H-7), 5.62 (1H, m, H-6), 5.26 (1H, d, J = 6.6 Hz, H-1), 4.65 (1H, d, J = 8.4 Hz, H-1′), 4.33 (1H, d, J = 15.1 Hz, H-10), 4.17 (1H, d, J = 15.7 Hz, H-10), 3.83 (1H, d, J = 11.7 Hz, H-6′), 3.59 (1H, m, H-6′), 3.59 (3H, s, H-12), 3.26–3.59 (4H, m, H-2′,3′,4′,5′), 3.17 (1H, m, H-9); 13C-NMR (CD3OD): 168.9 (C-11), 168.6 (C-9′), 161.0 (C-4′), 153.9 (C-3), 150.1 (C-8), 146.4 (C-7′), 131.0 (C-2′,6′), 127.1 (C-7,1′), 116.7 (C-3′,5′), 115.3 (C-8′), 109.8 (C-4), 100.2 (C-1″), 97.8 (C-1), 83.5 (C-6), 78.3 (C-3″), 77.8 (C-5″), 74.7 (C-2″), 71.4 (C-4″), 62.6 (C-6″), 60.9 (C-10), 52.0 (C-12), 46.9 (C-9), 42.3 (C-5).
3.6.2. 6-O-p-Coumaroyl Scandoside Methyl Ester (2)
C26H30O13; ESI/LTQ-Orbitrap-HRMS m/z: 549.1609 [M−H]−; 1H-NMR (DMSO-d6): 7.57 (1H, d, J = 14.4 Hz, H-α), 7.56 (2H, d, J = 9.0 Hz, H-6″), 7.54 (2H, d, J = 9.0 Hz, H-2″), 7.46 (1H, s, H-3), 6.79 (2H, d, J = 9.0 Hz, H-3″,5″), 6.38 (1H, d, J = 16.2 Hz, H-β), 5.73 (1H, m, H-7), 5.28 (1H, d, J = 5.4 Hz, H-1), 3.57 (3H, s, -COOCH3); 13C-NMR (DMSO-d6): 166.6 (C-11), 166.2 (C-CO), 160.0 (C-4″), 152.5 (C-3), 150.1 (C-8), 144.8 (C-α), 130.4 (C-2″,6″), 125.2 (C-1″), 124.9 (C-7), 115.9 (C-3″,5″), 114.4 (C-β), 108.3 (C-4), 98.6 (C-1′), 95.3 (C-1), 81.6 (C-6), 77.4 (C-3′), 76.7 (C-5′), 73.3 (C-2′), 70.1 (C-4′), 61.2 (C-6′), 59.1 (C-10), 51.3 (C-12), 45.7 (C-9), 40.3 (C-5).
3.6.3. E-6-O-Feruloyl Scandoside Methyl ester (3)
C27H32O14; ESI/LTQ-Orbitrap-HRMS m/z: 579.1732 [M−H]−; 1H-NMR (DMSO-d6): 7.53 (1H, d, J = 15.6 Hz, H-α), 7.41 (1H, s, H-3), 7.10 (1H, d, J = 1.2 Hz, H-2″), 7.08 (1H, dd, J = 1.2, 8.4 Hz, H-6″), 6.76 (1H, d, J = 8.4 Hz), 6.29 (1H, d, J = 15.6 Hz, H-β), 5.75 (1H, m, H-7), 5.58 (1H, m, H-6), 5.22 (1H, d, J = 6.6 Hz, H-1), 4.60 (1H, d, J = 7.8 Hz, H-1′), 4.30 (1H, d, J = 15.0 Hz, H-10), 4.13 (1H, d, J = 15.6 Hz, H-10), 3.79 (1H, s, -OMe), 3.78 (1H, d, J = 12.0 Hz, H-6′), 3.55 (1H, m, H-6′), 3.53 (1H, s, H-12), 3.24 (1H, d, J = 7.2 Hz, H-5), 3.24 (1H, m, H-3′), 3.17 (1H, m, H-5′), 3.12 (1H, m, H-4′), 3.11 (1H, m, H-2′), 2.96 (1H, dd, J = 4.2, 4.2 Hz, H-9); 13C-NMR (DMSO-d6): 166.5 (C-11), 166.1 (CO), 152.3 (C-3), 149.9 (C-8), 149.3 (C-3″), 147.9 (C-4″), 145.0 (C-α), 125.6 (C-1″), 124.7 (C-7), 123.1 (C-6″), 115.5 (C-5″), 114.6 (C-β), 111.2 (C-2″), 108.1 (C-4), 98.4 (C-1′), 95.1 (C-1), 81.4 (C-6), 77.3 (C-3′), 76.5 (C-5′), 73.2 (C-2′), 70.0 (C-4′), 61.0 (C-6′), 58.9 (C-10), 55.6 (-OMe), 51.1 (C-12), 45.6 (C-9), 40.1 (C-5).
3.6.4. Deacetylasperulosidic Acid Methyl ester (4)
C17H24O11; ESI/LTQ-Orbitrap-HRMS m/z: 403.1252 [M−H]−; 1H-NMR (CD3OD): 7.63 (1H, d, J = 1.6 Hz, H-3), 5.99 (1H, d, J = 2.1 Hz, H-7), 5.04 (1H, d, J = 9.0 Hz, H-1), 4.70 (1H, d, J = 7.8 Hz, H-1′), 4.44 (1H, d, J = 16.2 Hz, H-10), 4.19 (1H, d, J = 15.6 Hz, H-10), 3.74 (3H, s, COCH3), 3.00 (1H, ddd, J = 6.6, 5.4, 1.2 Hz, H-5), 2.55 (1H, dd, J = 8.4, 7.8 Hz, H-9); 13C-NMR (CD3OD): 169.4 (C-11), 155.3 (C-3), 151.5 (C-8), 129.7 (C-7), 108.2 (C-4), 101.5 (C-1), 100.4 (C-1′), 78.5 (C-3′), 77.8 (C-5′), 75.3 (C-6), 74.9 (C-2′), 71.6 (C-4′), 62.8 (C-6′), 61.6 (C-10), 51.8 (COCH3), 45.8 (C-9), 42.6 (C-5).
3.6.5. Asperuloside (5)
C18H22O11; ESI/LTQ-Orbitrap-HRMS m/z: 413.1093 [M−H]−; 1H-NMR (CD3OD): 7.29 (1H, d, J = 1.8 Hz, H-3), 5.95 (1H, s, H-7), 5.72 (1H, d, J = 2.2 Hz, H-1), 5.56 (1H, d, J = 6.0 Hz, H-6), 4.85 (1H, s, H-10), 4.68 (1H, d, J = 7.8 Hz, H-1′), 4.33–3.15 (1H, m, H-2′,3′,4′, and 5′), 3.90–3.65 (1H, m, H-6′), 3.64–3.17 (1H, m, H-5,9), 2.06 (1H, s, AcO); 13C-NMR (150 MHz, CD3OD): 172.5 (AcO), 172.2 (C-11), 150.2 (C-3,8), 129.1 (C-7), 106.1 (C-4), 99.9 (C-1), 93.2 (C-1′), 86.3 (C-6), 78.3 (C-3′), 77.8 (C-5′), 74.6 (C-2′), 71.5 (C-4′), 62.7 (C-6′), 61.9 (C-10), 45.2 (C-9), 37.4 (C-5).
3.6.6. 6-O-Methyldeacetylasperulosidic Acid Methyl Ester (6)
C18H26O11; ESI/LTQ-Orbitrap-HRMS m/z: 417.1402 [M−H]−; 1H-NMR (CD3OD): 7.68 (1H, d, J = 1.2 Hz, H-3), 6.24 (1H, d, J = 2.4 Hz, H-7), 5.04 (1H, d, J = 9.0 Hz, H-1), 4.78 (1H, d, J = 7.8 Hz, H-1′), 4.55 (1H, dd, J = 14.4, 1.8 Hz, H-10), 4.53 (1H, ddd, J = 6.6, 1.8, 1.8 Hz, H-6), 4.28 (1H, d, J = 15.6 Hz, H-10), 3.90 (1H, dd, J = 12.0, 1.8 Hz, H-6′), 3.81 (3H, s, 11-COOMe), 3.74 (1H, dd, J = 12.6, 5.4 Hz, H-6′), 3.32 (3H, s, 6-OMe), 3.15 (1H, ddd, J = 7.2, 6.0, 1.2 Hz, H-5); 13C-NMR (CD3OD): 169.4 (C-11), 155.0 (C-3), 152.8 (C-8), 127.5 (C-7), 108.1 (C-4), 101.7 (C-1), 100.7 (C-1′), 84.9 (C-6), 78.2 (C-5′), 77.8 (C-3′), 74.9 (C-2′), 71.3 (C-4′), 62.4 (C-6′), 61.7 (C-10), 57.3 (6-OMe), 51.8 (11-COOMe), 45.9 (C-9), 42.0 (C-5).
3.6.7. 6-O-Methylscandoside Methyl Ester (7)
C18H26O11; ESI/LTQ-Orbitrap-HRMS m/z: 417.1402 [M−H]−; 1H-NMR (CD3OD): 7.31 (1H, d, J = 0.7 Hz, H-3), 5.74 (1H, t, J = 2.0 Hz, H-7), 5.54 (1H, d, J = 3.6 Hz, H-1), 4.50 (1H, d, J = 7.8 Hz, H-1′), 4.19 (1H, dd, J = 15.0, 1.2 Hz, H-10), 4.11 (1H, s, H-6), 4.08 (1H, d, J = 15.4 Hz, H-10), 3.80 (1H, dd, J = 11.4, 1.8 Hz, H-6′), 3.62 (3H, s, 11-COOMe), 3.57 (1H, dd, J = 12.0, 6.0 Hz, H-6′), 3.34 (3H, s, 6-OMe), 3.20 (2H, m, H-5,9); 13C-NMR (CD3OD): 169.0 (C-11), 153.5 (C-3), 149.6 (C-8), 127.3 (C-7), 110.4 (C-4), 99.9 (C-1′), 95.1 (C-1), 89.9 (C-6), 78.3 (C-3′), 77.9 (C-5′), 74.6 (C-2′), 71.5 (C-4′), 62.7 (C-6′), 60.3 (C-10), 57.0 (6-OMe), 51.6 (11-COOMe), 47.4 (C-9), 39.0 (C-5).
3.6.8. Scandoside Methyl Ester (8)
C17H24O11; ESI/LTQ-Orbitrap-HRMS m/z: 403.1249 [M−H]−; 1H-NMR (CD3OD): 7.50 (1H, d, J = 1.8 Hz, H-3), 5.79 (1H, t, J = 2.4 Hz, H-7), 5.19 (1H, d, J = 7.2 Hz, H-1), 4.66 (1H, d, J = 8.4 Hz, H-1′), 4.54 (1H, dd, J = 4.2, 1.8 Hz, H-6), 4.34 (1H, d, J = 15.6 Hz, H-10), 4.18 (1H, d, J = 15.6 Hz, H-10), 3.84 (1H, dd, J = 12.6, 1.2 Hz, H-6′), 3.74 (3H, s, COOMe), 3.64 (1H, dd, J = 12.6, 5.4 Hz, H-6′), 3.25–3.37 (4H, m, H-2′,3′,4′, and 5′), 3.02 (1H, t, J = 6.6 Hz, H-9), 2.99 (1H, ddd, J = 7.2, 4.8, 1.2 Hz, H-5); 13C-NMR (CD3OD): 170.2 (C-11), 153.8 (C-3), 147.5 (C-8), 130.0 (C-7), 110.7 (C-4), 100.2 (C-1′), 98.26 (C-1), 82.2 (C-6), 78.4 (C-5′), 77.8 (C-3′), 74.7 (C-2′), 71.5 (C-4′), 62.6 (C-6′), 61.0 (C-10), 52.0 (COOMe), 47.1 (C-9), 45.5 (C-5).
3.6.9. Asperulosidic Acid (9)
C18H24O12; ESI/LTQ-Orbitrap-HRMS m/z: 431.1192 [M−H]−; 1H-NMR (CD3OD): 7.51 (1H, d, J = 1.0 Hz, H-3), 5.89 (1H, d, J = 1.0 Hz, H-7), 4.93 (1H, d, J = 9.0 Hz, H-1), 4.82 (1H, s, H-6), 4.74 (1H, d, J = 15.6 Hz, H-10), 4.66 (1H, d, J = 15.0 Hz, H-10), 4.60 (1H, d, J = 7.2 Hz, H-1′), 3.73 (1H, dd, J = 12.0, 1.8 Hz, H-6′), 3.50 (1H, dd, J = 12.0, 6.6 Hz, H-6′), 3.09–3.29 (1H, m, H-2′,3′,4′, and 5′), 2.89 (1H, t, J = 6.0 Hz, H-5), 2.50 (1H, t, J = 8.4 Hz, H-9), 1.96 (1H, s, Ac-Me); 13C-NMR (CD3OD): 172.5 (CO-AcO, C-11), 155.1 (C-3), 145.9 (C-8), 131.8 (C-7), 108.7 (C-4), 101.1 (C-1), 100.5 (C-1′), 78.5 (C-3′), 77.8 (C-5′), 75.4 (C-6), 74.9 (C-2′), 71.5 (C-4′), 63.8 (C-10), 62.9 (C-6′), 46.2 (C-9), 42.5 (C-5), 20.8 (Ac-Me).
3.6.10. Quercetin-3-O-[2′′-O-(6′′′-O-E-feruolyl)-β-d-glucopyranosyl]-β-d-glucopyranoside (10)
C37H38O20; ESI/LTQ-Orbitrap-HRMS m/z: 803.2200 [M−H]−; 1H-NMR (CD3OD): 7.60 (1H, dd, J = 8.4, 2.4 Hz, H-6′), 7.57 (1H, d, J = 1.8 Hz, H-2′), 7.31 (1H, d, J = 15.6 Hz, H-α), 6.85 (1H, d, J = 8.4 Hz, H-5′), 6.77 (1H, d, J = 1.2 Hz, H-2‴), 6.69 (1H, dd, J = 8.4, 1.2 Hz, H-6‴), 6.62 (1H, d, J = 7.8 Hz, H-5‴), 6.08 (1H, d, J = 1.2 Hz, H-8), 6.02 (1H, d, J = 16.2 Hz, H-β), 5.99 (1H, d, J = 1.2 Hz, H-6), 5.18 (1H, d, J = 7.2 Hz, H-1″), 4.74 (1H, d, J = 7.8 Hz, H-1‴), 3.74 (3H, s, OMe); 13C-NMR (CD3OD): 179.7 (C-4), 168.9 (C-γ), 165.7 (C-7), 162.8 (C-5), 158.2 (C-9), 158.1 (C-2), 150.3 (C-4‴), 149.7 (C-4′), 149.0 (C-3‴), 146.7 (C-α), 145.9 (C-3′), 135.1 (C-3), 127.3 (C-1‴), 123.8 (C-6‴), 123.7 (C-6′), 122.9 (C-1′), 117.3 (C-5′), 116.2 (C-2′, 5‴), 114.8 (C-β), 111.1 (C-2‴), 106.0 (C-1‴), 105.6 (C-10), 101.0 (C-1″), 99.8 (C-6), 94.7 (C-8), 84.7 (C-2″), 78.1 (C-3″), 77.7 (C-5″), 77.6 (C-3‴), 76.0 (C-2‴), 75.7 (C-5‴), 71.8 (C-4″), 70.8 (C-4‴), 64.5 (C-6‴), 62.2 (C-6″), 56.2 (OMe).